Frontlight ResearchEarly access
Down syndrome trials in United Kingdom
1 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Where
- Cambridge, Liverpool, London, Oxford, Warrington
- Age
- 35 years to 85 years
- People
- 304 worldwide
- Run by
- AC Immune SA
See details and how to joinNCT05462106 · EU 2022-500069-29-00